Literature DB >> 10854948

Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?

H Eerola1, C Blomqvist, E Pukkala, S Pyrhönen, H Nevanlinna.   

Abstract

We evaluate the validity of the family history of breast cancer reported by the patient and the number of families and individuals at risk and potentially benefiting from surveillance. Family history of cancer was systematically screened in three different series of breast cancer patients. Breast cancer families were defined by the selection criterion of at least three first- or second-degree relatives with breast or ovarian cancer (including the proband) and their genealogy and cancer diagnoses were confirmed. Family history of breast or ovarian cancer was reported by approximately 30% of the patients and 7-9% were classified as breast cancer families. On average, there were 3.1 healthy female (age: 20-70 years) first degree relatives per family potentially at high risk. Index patients reported 87% of all confirmed diagnoses and the primary site was correct in 93-95% of the reported cases. The incompleteness and errors in accuracy should be considered in epidemiological studies and verification of the diagnoses is important when deciding clinical management.

Entities:  

Mesh:

Year:  2000        PMID: 10854948     DOI: 10.1016/s0959-8049(00)00093-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  38 in total

1.  A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.

Authors:  Pia Vahteristo; Jirina Bartkova; Hannaleena Eerola; Kirsi Syrjäkoski; Salla Ojala; Outi Kilpivaara; Anitta Tamminen; Juha Kononen; Kristiina Aittomäki; Päivi Heikkilä; Kaija Holli; Carl Blomqvist; Jiri Bartek; Olli-P Kallioniemi; Heli Nevanlinna
Journal:  Am J Hum Genet       Date:  2002-07-28       Impact factor: 11.025

2.  Breast cancer risk among Finnish cabin attendants: a nested case-control study.

Authors:  K Kojo; E Pukkala; A Auvinen
Journal:  Occup Environ Med       Date:  2005-07       Impact factor: 4.402

3.  Screening of HELQ in breast and ovarian cancer families.

Authors:  Liisa M Pelttari; Laura Kinnunen; Johanna I Kiiski; Sofia Khan; Carl Blomqvist; Kristiina Aittomäki; Heli Nevanlinna
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

4.  The impact of cancer pathology confirmation on clinical management of a family history of cancer.

Authors:  E Edwards; A Lucassen
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

5.  Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County.

Authors:  Sara Margolin; Hemming Johansson; Lars Erik Rutqvist; Annika Lindblom; Tommy Fornander
Journal:  Fam Cancer       Date:  2006-07-01       Impact factor: 2.375

6.  Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome.

Authors:  Maral Jamshidi; Marjanka K Schmidt; Thilo Dörk; Montserrat Garcia-Closas; Tuomas Heikkinen; Sten Cornelissen; Alexandra J van den Broek; Peter Schürmann; Andreas Meyer; Tjoung-Won Park-Simon; Jonine Figueroa; Mark Sherman; Jolanta Lissowska; Garrett Teoh Hor Keong; Astrid Irwanto; Marko Laakso; Sampsa Hautaniemi; Kristiina Aittomäki; Carl Blomqvist; Jianjun Liu; Heli Nevanlinna
Journal:  Int J Cancer       Date:  2012-10-25       Impact factor: 7.396

7.  Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.

Authors:  Yen Ling Low; Yuqing Li; Keith Humphreys; Anbupalam Thalamuthu; Yi Li; Hatef Darabi; Sara Wedrén; Carine Bonnard; Kamila Czene; Mark M Iles; Tuomas Heikkinen; Kristiina Aittomäki; Carl Blomqvist; Heli Nevanlinna; Per Hall; Edison T Liu; Jianjun Liu
Journal:  PLoS Genet       Date:  2010-07-01       Impact factor: 5.917

Review 8.  Familial pancreatic cancer.

Authors:  Harald Rieder; Detlef K Bartsch
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

9.  Literacy assessment of family health history tools for public health prevention.

Authors:  C Wang; R E Gallo; L Fleisher; S M Miller
Journal:  Public Health Genomics       Date:  2010-01-04       Impact factor: 2.000

10.  ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer.

Authors:  Sanna Siltanen; Kirsi Syrjäkoski; Rainer Fagerholm; Tarja Ikonen; Peter Lipman; Jacob Mallott; Kaija Holli; Teuvo L J Tammela; Heikki J Järvinen; Jukka-Pekka Mecklin; Kristiina Aittomäki; Carl Blomqvist; Joan E Bailey-Wilson; Heli Nevanlinna; Lauri A Aaltonen; Johanna Schleutker; Pia Vahteristo
Journal:  Eur J Hum Genet       Date:  2008-03-12       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.